Legal & General Group PLC Axonics, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Axonics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 68,231 shares of AXNX stock, worth $4.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,231

Previous 68,231 -0.0%

Holding current value

$4.84 Million

Previous $4.75 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$67.3 - $69.67 $826,511 - $855,617	12,281 Added 21.95%	68,231 $4.75 Million
Q2 2024 Aug 14, 2024	BUY	$66.47 - $69.65 $271,397 - $284,380	4,083 Added 7.87%	55,950 $3.76 Million
Q1 2024 May 14, 2024	BUY	$56.67 - $69.36 $56,103 - $68,666	990 Added 1.95%	51,867 $3.58 Million
Q4 2023 Feb 15, 2024	BUY	$49.38 - $63.75 $13,925 - $17,977	282 Added 0.56%	50,877 $3.17 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $117,465 - $150,961	2,415 Added 5.01%	50,595 $2.84 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $314,190 - $394,194	6,547 Added 15.73%	48,180 $2.43 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $104,831 - $134,208	1,993 Added 5.03%	41,633 $2.27 Million
Q4 2022 Feb 14, 2023	SELL	$59.56 - $76.6 $15,545 - $19,992	-261 Reduced 0.65%	39,640 $2.48 Million
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $98,474 - $132,725	-1,699 Reduced 4.08%	39,901 $2.81 Million
Q2 2022 Aug 22, 2022	BUY	$39.5 - $64.42 $186,558 - $304,255	4,723 Added 12.81%	41,600 $2.36 Million
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $481 - $690	11 Added 0.03%	36,877 $2.31 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $24,754 - $36,308	495 Added 1.36%	36,866 $2.06 Million
Q3 2021 Nov 15, 2021	BUY	$59.21 - $78.66 $1.62 Million - $2.15 Million	27,395 Added 305.2%	36,371 $2.37 Million
Q2 2021 Aug 12, 2021	BUY	$51.39 - $66.9 $93,735 - $122,025	1,824 Added 25.5%	8,976 $569,000
Q1 2021 May 17, 2021	SELL	$49.14 - $59.89 $13,022 - $15,870	-265 Reduced 3.57%	7,152 $428,000
Q4 2020 Feb 12, 2021	SELL	$42.19 - $51.5 $23,331 - $28,479	-553 Reduced 6.94%	7,417 $370,000
Q3 2020 Nov 13, 2020	SELL	$35.33 - $51.04 $19,537 - $28,225	-553 Reduced 6.49%	7,970 $407,000
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $112,373 - $195,366	4,905 Added 135.57%	8,523 $299,000
Q1 2020 May 14, 2020	SELL	$16.44 - $37.73 $2,646 - $6,074	-161 Reduced 4.26%	3,618 $92,000
Q4 2019 Feb 13, 2020	BUY	$19.57 - $28.96 $23,562 - $34,867	1,204 Added 46.76%	3,779 $105,000
Q2 2019 Aug 14, 2019	BUY	$18.54 - $40.97 $27,921 - $61,700	1,506 Added 140.88%	2,575 $96,000
Q4 2018 Feb 15, 2019	BUY	$13.2 - $16.43 $14,110 - $17,563	1,069 New	1,069 $16,000

Others Institutions Holding AXNX

# of Institutions

235

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Axonics, Inc. Transaction History